CORCEPT THERAPEUTICS INC Shareholders' Equity
CORCEPT THERAPEUTICS INC (CORT) had Shareholders' Equity of $705.78 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-29
- 2026-06-30: Stockholders' Equity Attributable to Parent $705.78M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $637.99M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $647.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $631.90M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $705.78M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $637.99M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $647.80M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $631.90M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $635.79M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $683.28M 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $679.59M 10-Q · filed 2026-07-29 | |
| 2024-09-30 | $638.84M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $596.24M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $547.86M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $506.70M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $461.68M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $421.61M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $529.58M 10-Q · filed 2024-10-30 | |
| 2022-12-31 | $501.84M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $473.36M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $442.33M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $407.81M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $375.81M 10-K · filed 2025-02-26 | |
| 2021-09-30 | $540.23M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $522.67M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $510.80M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $523.34M 10-K · filed 2024-02-15 | |
| 2020-09-30 | $489.68M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $453.70M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $409.49M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $371.18M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $334.38M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $298.05M 10-Q · filed 2020-11-03 | |
| 2019-03-31 | $285.75M 10-Q · filed 2020-11-03 | |
| 2018-12-31 | $275.88M 10-K · filed 2022-02-15 | |
| 2018-09-30 | $259.55M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $243.51M 10-Q · filed 2019-11-07 | $243.51M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $215.23M 10-Q · filed 2019-11-07 | $215.23M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $190.97M 10-K · filed 2021-02-23 | |
| 2017-09-30 | $86.30M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $66.14M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $49.58M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $41.38M 10-K · filed 2020-02-24 | |
| 2016-09-30 | $31.25M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $25.66M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $20.17M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $18.50M 10-K · filed 2019-02-26 | |
| 2015-09-30 | $13.48M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $11.53M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $10.57M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$3.39M 10-K · filed 2018-02-28 | |
| 2014-09-30 | -$1.32M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $3.45M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $9.37M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $21.02M 10-K · filed 2017-03-06 | |
| 2013-09-30 | $30.77M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $40.37M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $51.00M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $61.78M 10-K · filed 2016-03-10 | |
| 2012-09-30 | $71.65M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $32.80M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $39.32M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $34.81M 10-K · filed 2015-03-13 | |
| 2011-09-30 | $43.67M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $48.86M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $21.24M 10-K · filed 2014-03-14 | |
| 2009-12-31 | $22.09M 10-K · filed 2013-03-15 | |
| 2008-12-31 | $16.91M 10-K · filed 2012-03-13 | |
| 2007-12-31 | $14.73M 10-K · filed 2012-03-13 | |
| 2006-12-31 | $6.36M 10-K · filed 2012-03-13 | |
| 2005-12-31 | $26.59M 10-K · filed 2012-03-13 | |
| 2004-12-31 | $45.95M 10-K · filed 2012-03-13 | |
| 2003-12-31 | -$31.47M 10-K · filed 2012-03-13 | |
| 2002-12-31 | -$21.94M 10-K · filed 2012-03-13 | |
| 2001-12-31 | -$7.54M 10-K · filed 2012-03-13 | |
| 2000-12-31 | -$2.00M 10-K · filed 2012-03-13 | |
| 1999-12-31 | -$244.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |